This week, Mecwins had the pleasure of welcoming representatives from Almenara Capital Partners, accompanied by a group of potential investors for their Lifetech Innovation Fund, to our headquarters in Tres Cantos (Madrid).
During the visit, our guests had the opportunity to explore Mecwins’ facilities, including our biotechnology laboratory—equipped with state-of-the-art instrumentation—and our engineering lab, where our team develops and tests our proprietary AVAC technology.
Our CEO, Oscar Ahumada, PhD, shared insights into Mecwins’ mission, our scientific and technological achievements, and our vision for the future of ultrasensitive biosensing. The presentation highlighted how Mecwins’ innovations are poised to contribute to advances in life sciences, diagnostics, and personalized medicine.
The visit was an excellent opportunity to showcase Mecwins’ commitment to excellence, innovation, and collaboration within the Lifetech ecosystem fostered by Almenara Capital Partners. We sincerely thank them and all the investors for their interest and for taking the time to learn more about our company.
